WO1991019711A1 - Substituted benzimidazoles, process for their preparation and their pharmaceutical use - Google Patents
Substituted benzimidazoles, process for their preparation and their pharmaceutical use Download PDFInfo
- Publication number
- WO1991019711A1 WO1991019711A1 PCT/SE1991/000415 SE9100415W WO9119711A1 WO 1991019711 A1 WO1991019711 A1 WO 1991019711A1 SE 9100415 W SE9100415 W SE 9100415W WO 9119711 A1 WO9119711 A1 WO 9119711A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- compound
- formula
- pyridinyl
- dimethoxy
- Prior art date
Links
- 0 Cc1nc2cc(*=O)c(*)cc2[n]1C Chemical compound Cc1nc2cc(*=O)c(*)cc2[n]1C 0.000 description 2
- ODCKFUPHXJWCAL-UHFFFAOYSA-N CCN1C2=CC(C)=C(C)CC2N(C)C1 Chemical compound CCN1C2=CC(C)=C(C)CC2N(C)C1 ODCKFUPHXJWCAL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP91511435A JPH05507713A (en) | 1990-06-20 | 1991-06-11 | Substituted benzimidazoles, their manufacturing methods and their pharmaceutical uses |
AU80097/91A AU649453B2 (en) | 1990-06-20 | 1991-06-11 | Substituted benzimidazoles, process for their preparation and their pharmaceutical use |
RO92-01581A RO110493B1 (en) | 1990-06-20 | 1991-06-11 | Benzimidazole derivates and preparation processes therefor |
NO924775A NO924775D0 (en) | 1990-06-20 | 1992-12-10 | SUBSTITUTED BENZIMIDAZOLES, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE |
FI925766A FI925766A0 (en) | 1990-06-20 | 1992-12-18 | SUBSTITUTE BENSIMIDAZOLER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS PHARMACEUTISKA ANVAENDNING |
LV931045A LV10953A (en) | 1990-06-20 | 1993-08-27 | Substituted benzimidazoles for use in the manufacture of a pharmaceutical composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002206A SE9002206D0 (en) | 1990-06-20 | 1990-06-20 | NEW COMPOUNDS |
SE9002206-2 | 1990-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1991019711A1 true WO1991019711A1 (en) | 1991-12-26 |
Family
ID=20379831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1991/000415 WO1991019711A1 (en) | 1990-06-20 | 1991-06-11 | Substituted benzimidazoles, process for their preparation and their pharmaceutical use |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0535081A1 (en) |
JP (1) | JPH05507713A (en) |
CN (1) | CN1058212A (en) |
AP (1) | AP215A (en) |
AU (1) | AU649453B2 (en) |
CA (1) | CA2083714A1 (en) |
CZ (1) | CZ279772B6 (en) |
FI (1) | FI925766A0 (en) |
HU (1) | HUT62881A (en) |
IE (1) | IE912025A1 (en) |
IL (1) | IL98470A0 (en) |
IS (1) | IS3721A7 (en) |
LT (2) | LT3952B (en) |
LV (1) | LV10953A (en) |
MA (1) | MA22199A1 (en) |
NO (1) | NO924775D0 (en) |
NZ (1) | NZ238546A (en) |
OA (1) | OA09682A (en) |
PT (1) | PT98035A (en) |
RO (1) | RO110493B1 (en) |
SE (1) | SE9002206D0 (en) |
TN (1) | TNSN91049A1 (en) |
TW (1) | TW216418B (en) |
WO (1) | WO1991019711A1 (en) |
YU (1) | YU104191A (en) |
ZA (2) | ZA914296B (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995015962A1 (en) * | 1993-12-06 | 1995-06-15 | Astra Aktiebolag | Substituted benzimidazole, processes for its preparation and its pharmaceutical use |
AU665043B2 (en) * | 1991-12-19 | 1995-12-14 | Astra Aktiebolag | Substituted benzimidazoles, process for their preparation as well as their use |
US6013281A (en) * | 1995-02-09 | 2000-01-11 | Astra Aktiebolag | Method of making a pharmaceutical dosage form comprising a proton pump inhibitor |
US6136344A (en) * | 1995-02-06 | 2000-10-24 | Astra Aktiebolag | Oral pharmaceutical dosage form |
US6617338B2 (en) | 2000-02-24 | 2003-09-09 | Kopran Research Laboratories Limited | Orally administrable acid stable antiulcer benzimidazole derivatives |
WO2004035090A1 (en) | 2002-10-16 | 2004-04-29 | Orexo Ab | Gastric acid secretion inhibiting composition |
WO2008012621A2 (en) | 2006-07-25 | 2008-01-31 | Vecta, Ltd. | Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US7815940B2 (en) | 2001-04-18 | 2010-10-19 | Orexo Ab | Gastric acid secretion inhibiting composition |
EP2275139A1 (en) | 1996-01-08 | 2011-01-19 | AstraZeneca AB | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080501A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US8226979B2 (en) | 2003-09-26 | 2012-07-24 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
EP2601938A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Pharmaceutical compositions for the treatment of Helicobacter pylori associated diseases |
KR101285696B1 (en) * | 2005-04-15 | 2013-07-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Benzimidazole compound |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US8852636B2 (en) | 2001-06-01 | 2014-10-07 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8945621B2 (en) | 2009-06-25 | 2015-02-03 | Pozen Inc. | Method for treating a patient at risk for developing an NSAID-associated ulcer |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US9220698B2 (en) | 2008-09-09 | 2015-12-29 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
US9814684B2 (en) | 2002-04-09 | 2017-11-14 | Flamel Ireland Limited | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
AU2021200290B2 (en) * | 2016-09-14 | 2023-09-14 | National Health Research Institutes | Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002043D0 (en) * | 1990-06-07 | 1990-06-07 | Astra Ab | IMPROVED METHOD FOR SYNTHESIS |
TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
WO2007122686A1 (en) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | Benzimidazole compounds |
US20110009624A9 (en) * | 2006-10-13 | 2011-01-13 | Masato Ueda | Benzimidazole compounds having gastric acid secretion inhibitory action |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0176308A2 (en) * | 1984-09-24 | 1986-04-02 | The Upjohn Company | 2-(Pyridylalkylenesulfinyl) benzimidazoles |
EP0221041A2 (en) * | 1985-10-29 | 1987-05-06 | Aktiebolaget Hässle | Benzimidazole derivatives, process for their preparation and their pharmaceutical use |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418966B (en) | 1974-02-18 | 1981-07-06 | Haessle Ab | ANALOGY PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH Gastric Acid Secretion Inhibitory Effects |
SE416649B (en) | 1974-05-16 | 1981-01-26 | Haessle Ab | PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion |
IN148930B (en) | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
SE7804231L (en) | 1978-04-14 | 1979-10-15 | Haessle Ab | Gastric acid secretion |
US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
CH644116A5 (en) | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | IMIDAZOLE DERIVATIVES. |
SE8300736D0 (en) | 1983-02-11 | 1983-02-11 | Haessle Ab | NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS |
SE8301182D0 (en) | 1983-03-04 | 1983-03-04 | Haessle Ab | NOVEL COMPOUNDS |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
NZ222495A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | Benzimidazole derivatives and pharmaceutical compositions |
DE3722810A1 (en) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE USE THEREOF |
EP0338066A1 (en) * | 1987-10-30 | 1989-10-25 | Aktiebolaget Hässle | 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss |
EP0390842A1 (en) * | 1987-12-11 | 1990-10-10 | Byk Gulden Lomberg Chemische Fabrik GmbH | Novel benzimidazole derivatives |
EP0415990A1 (en) * | 1988-05-25 | 1991-03-13 | Byk Gulden Lomberg Chemische Fabrik GmbH | New fluoralkoxy compounds |
-
1990
- 1990-06-20 SE SE9002206A patent/SE9002206D0/en unknown
-
1991
- 1991-06-05 ZA ZA914296A patent/ZA914296B/en unknown
- 1991-06-05 ZA ZA914297A patent/ZA914297B/en unknown
- 1991-06-11 EP EP91911659A patent/EP0535081A1/en not_active Withdrawn
- 1991-06-11 CA CA002083714A patent/CA2083714A1/en not_active Abandoned
- 1991-06-11 RO RO92-01581A patent/RO110493B1/en unknown
- 1991-06-11 WO PCT/SE1991/000415 patent/WO1991019711A1/en not_active Application Discontinuation
- 1991-06-11 AU AU80097/91A patent/AU649453B2/en not_active Ceased
- 1991-06-11 JP JP91511435A patent/JPH05507713A/en active Pending
- 1991-06-11 HU HU924033A patent/HUT62881A/en unknown
- 1991-06-12 IL IL98470A patent/IL98470A0/en unknown
- 1991-06-12 TW TW080104582A patent/TW216418B/zh active
- 1991-06-12 YU YU104191A patent/YU104191A/en unknown
- 1991-06-14 NZ NZ238546A patent/NZ238546A/en unknown
- 1991-06-14 IE IE202591A patent/IE912025A1/en unknown
- 1991-06-18 MA MA22462A patent/MA22199A1/en unknown
- 1991-06-19 AP APAP/P/1991/000285A patent/AP215A/en active
- 1991-06-19 PT PT98035A patent/PT98035A/en not_active Application Discontinuation
- 1991-06-19 TN TNTNSN91049A patent/TNSN91049A1/en unknown
- 1991-06-20 IS IS3721A patent/IS3721A7/en unknown
- 1991-06-20 CN CN91105024A patent/CN1058212A/en active Pending
- 1991-06-20 CZ CS911894A patent/CZ279772B6/en unknown
-
1992
- 1992-11-27 OA OA60306A patent/OA09682A/en unknown
- 1992-12-10 NO NO924775A patent/NO924775D0/en unknown
- 1992-12-18 FI FI925766A patent/FI925766A0/en not_active Application Discontinuation
-
1993
- 1993-08-27 LV LV931045A patent/LV10953A/en unknown
- 1993-12-30 LT LTIP1712A patent/LT3952B/en not_active IP Right Cessation
- 1993-12-30 LT LTIP1713A patent/LT3977B/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0176308A2 (en) * | 1984-09-24 | 1986-04-02 | The Upjohn Company | 2-(Pyridylalkylenesulfinyl) benzimidazoles |
EP0221041A2 (en) * | 1985-10-29 | 1987-05-06 | Aktiebolaget Hässle | Benzimidazole derivatives, process for their preparation and their pharmaceutical use |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU665043B2 (en) * | 1991-12-19 | 1995-12-14 | Astra Aktiebolag | Substituted benzimidazoles, process for their preparation as well as their use |
WO1995015962A1 (en) * | 1993-12-06 | 1995-06-15 | Astra Aktiebolag | Substituted benzimidazole, processes for its preparation and its pharmaceutical use |
US6136344A (en) * | 1995-02-06 | 2000-10-24 | Astra Aktiebolag | Oral pharmaceutical dosage form |
US6013281A (en) * | 1995-02-09 | 2000-01-11 | Astra Aktiebolag | Method of making a pharmaceutical dosage form comprising a proton pump inhibitor |
EP2275139A1 (en) | 1996-01-08 | 2011-01-19 | AstraZeneca AB | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
US6617338B2 (en) | 2000-02-24 | 2003-09-09 | Kopran Research Laboratories Limited | Orally administrable acid stable antiulcer benzimidazole derivatives |
US7815940B2 (en) | 2001-04-18 | 2010-10-19 | Orexo Ab | Gastric acid secretion inhibiting composition |
EP2253309A2 (en) | 2001-04-18 | 2010-11-24 | Orexo AB | Gastric acid secretion inhibiting composition |
US9364439B2 (en) | 2001-06-01 | 2016-06-14 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9198888B2 (en) | 2001-06-01 | 2015-12-01 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8858996B2 (en) | 2001-06-01 | 2014-10-14 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDS |
US8865190B2 (en) | 2001-06-01 | 2014-10-21 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9161920B2 (en) | 2001-06-01 | 2015-10-20 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8852636B2 (en) | 2001-06-01 | 2014-10-07 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9345695B2 (en) | 2001-06-01 | 2016-05-24 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9707181B2 (en) | 2001-06-01 | 2017-07-18 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9814684B2 (en) | 2002-04-09 | 2017-11-14 | Flamel Ireland Limited | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
US10004693B2 (en) | 2002-04-09 | 2018-06-26 | Flamel Ireland Limited | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
WO2004035090A1 (en) | 2002-10-16 | 2004-04-29 | Orexo Ab | Gastric acid secretion inhibiting composition |
EP2258341A2 (en) | 2002-10-16 | 2010-12-08 | Orexo AB | Gastric acid secretion inhibiting composition |
US7771747B2 (en) | 2002-10-16 | 2010-08-10 | Orexo Ab | Gastric acid secretion inhibiting composition |
US7785626B2 (en) | 2002-10-16 | 2010-08-31 | Orexo Ab | Gastric acid secretion inhibiting composition |
US8226979B2 (en) | 2003-09-26 | 2012-07-24 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
US8246986B2 (en) | 2003-09-26 | 2012-08-21 | Alza Corporation | Drug coating providing high drug loading |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
KR101285696B1 (en) * | 2005-04-15 | 2013-07-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Benzimidazole compound |
NO339502B1 (en) * | 2005-04-15 | 2016-12-19 | Eisai R&D Man Co Ltd | benzimidazole |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US9132082B2 (en) | 2005-05-11 | 2015-09-15 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US9370481B2 (en) | 2005-05-11 | 2016-06-21 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US9278080B2 (en) | 2005-05-11 | 2016-03-08 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US9233092B2 (en) | 2006-07-25 | 2016-01-12 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI |
WO2008012621A2 (en) | 2006-07-25 | 2008-01-31 | Vecta, Ltd. | Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi |
US9801824B2 (en) | 2008-09-09 | 2017-10-31 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
US9220698B2 (en) | 2008-09-09 | 2015-12-29 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
US9393208B2 (en) | 2008-09-09 | 2016-07-19 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
US8945621B2 (en) | 2009-06-25 | 2015-02-03 | Pozen Inc. | Method for treating a patient at risk for developing an NSAID-associated ulcer |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080501A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2601947A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
EP2601938A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Pharmaceutical compositions for the treatment of Helicobacter pylori associated diseases |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
US9987231B2 (en) | 2011-12-28 | 2018-06-05 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
US10603283B2 (en) | 2011-12-28 | 2020-03-31 | Genus Lifesciences, Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
AU2021200290B2 (en) * | 2016-09-14 | 2023-09-14 | National Health Research Institutes | Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors |
Also Published As
Publication number | Publication date |
---|---|
FI925766A (en) | 1992-12-18 |
HUT62881A (en) | 1993-06-28 |
ZA914297B (en) | 1992-03-25 |
LT3952B (en) | 1996-05-27 |
HU9204033D0 (en) | 1993-03-29 |
CS189491A3 (en) | 1992-04-15 |
YU104191A (en) | 1994-01-20 |
NO924775L (en) | 1992-12-10 |
IL98470A0 (en) | 1992-07-15 |
AU649453B2 (en) | 1994-05-26 |
EP0535081A1 (en) | 1993-04-07 |
TNSN91049A1 (en) | 1992-10-25 |
RO110493B1 (en) | 1996-01-30 |
IE912025A1 (en) | 1992-01-01 |
ZA914296B (en) | 1992-03-25 |
MA22199A1 (en) | 1992-04-01 |
LV10953A (en) | 1995-12-20 |
JPH05507713A (en) | 1993-11-04 |
LTIP1713A (en) | 1995-08-25 |
SE9002206D0 (en) | 1990-06-20 |
AP9100285A0 (en) | 1991-07-31 |
LT3977B (en) | 1996-06-25 |
PT98035A (en) | 1992-03-31 |
LTIP1712A (en) | 1995-08-25 |
IS3721A7 (en) | 1991-12-21 |
AU8009791A (en) | 1992-01-07 |
NZ238546A (en) | 1994-03-25 |
CN1058212A (en) | 1992-01-29 |
NO924775D0 (en) | 1992-12-10 |
AP215A (en) | 1992-09-02 |
CZ279772B6 (en) | 1995-06-14 |
OA09682A (en) | 1993-05-15 |
TW216418B (en) | 1993-11-21 |
FI925766A0 (en) | 1992-12-18 |
CA2083714A1 (en) | 1991-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP215A (en) | Substituted benzimidazoles, process for their preparation and their pharmaceutical use. | |
EP0593463B1 (en) | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
EP0449940B1 (en) | New therapeutically active compound and a process for its preparation | |
US4965269A (en) | Therapeutically active chloro substituted benzimidazoles | |
EP0451188B1 (en) | Therapeutically active substituted benzimidazole and process for its preparation | |
EP0449935B1 (en) | Compound with gastric acid inhibitory effect and process for its preparation | |
WO1987005021A1 (en) | Benzimidazoles and their pharmaceutical use | |
WO1995015962A1 (en) | Substituted benzimidazole, processes for its preparation and its pharmaceutical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH DE DK ES FI GB HU JP KP KR LK LU MC MG MW NL NO PL RO SD SE SU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991911659 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2083714 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 925766 Country of ref document: FI Ref document number: 92-01581 Country of ref document: RO |
|
WWP | Wipo information: published in national office |
Ref document number: 1991911659 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1991911659 Country of ref document: EP |